Pediatric Post-Approval Registry
Recruiting now
Conditions studied: Obstructive Sleep Apnea
In brief
This registry is a prospective, multi-center, single-arm study of pediatric subjects (ages 18-21 years) who are undergoing implant of the Inspire Upper Airway Stimulation (UAS) System for the treatment of moderate or severe obstructive sleep apnea (OSA). Implanted subjects will be followed for 5 years post-implant.
Key facts
- Study ID
- NCT04457154
- Run by
- Inspire Medical Systems, Inc.
- People needed
- 60
- Starts
- 2021-11-30
- Expected to finish
- 2028-04-01
- Last updated by the study team
- 2025-02-25
Who can join
Age: 18 and older, up to 21. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subject is between 18 and 21 years of age;
- Subject has a diagnosis of moderate to severe OSA (15 ≤ AHI ≤ 65) based on a recent sleep study;
- Subject has documented failure of, or intolerance to, positive airway pressure treatments, despite attempts to improve compliance;
- Subject is contraindicated for, or not effectively treated by, adenotonsillectomy;
- Subject has followed standard of care in considering all other alternative/adjunct therapies;
- Subject is willing and able to have stimulation hardware permanently implanted and to use the patient remote to activate the stimulation;
- Subject is willing and able to return for follow-up visits, undergo sleep studies (including in-lab and at-home), and complete questionnaires related to the registry;
- Subject is willing and able to provide informed consent.
You may not qualify if…
- Subject has a combination of central + mixed apneas > 25% of the total apnea-hypopnea index (AHI);
- Subject has any anatomical finding that would compromise the performance of upper airway stimulation, such as the presence of complete concentric collapse of the soft palate;
- Subject has any condition or procedure that has compromised neurological control of the upper airway;
- Subject is unable, or does not have the necessary assistance, to operate the patient remote;
- Subject is pregnant or plans to become pregnant;
- Subject has an implantable device that may be susceptible to unintended interaction with the Inspire System;
- Subject has a terminal illness with life expectancy < 12 months;
- Any other reason the investigator deems the subject is unfit for participation in the registry.
Where it is running
- Children's Hospital of the King's Daughters/East Virginia Medical School — Norfolk, Virginia, United States (enrolling)
- Childrens Hospital of Colorado — Aurora, Colorado, United States (enrolling)
- Duke University — Durham, North Carolina, United States (enrolling)
- Cincinnati Childrens Hospital — Cincinnati, Ohio, United States (enrolling)
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States (enrolling)
- Children's Hospital of Pittsburgh — Sewickley, Pennsylvania, United States (enrolling)
- University of Texas Southwestern/Children's Hospital of Dallas — Dallas, Texas, United States (enrolling)
- Children's Healthcare of Atlanta — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.